Abrdn Life Sciences Investors (HQL) Short Interest Ratio & Short Volume $12.99 -0.10 (-0.76%) Closing price 03/26/2025 03:58 PM EasternExtended Trading$12.99 0.00 (0.00%) As of 03/26/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Abrdn Life Sciences Investors Short Interest DataAbrdn Life Sciences Investors (HQL) has a short interest of 60,400 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a -37.41% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 98,022 shares to cover all short positions.Current Short Interest60,400 sharesPrevious Short Interest96,500 sharesChange Vs. Previous Month-37.41%Dollar Volume Sold Short$781,878.00Short Interest Ratio0.4 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares27,351,000 sharesShort Percent of Float0.25%Today's Trading Volume107,152 sharesAverage Trading Volume98,022 sharesToday's Volume Vs. Average109% Short Selling Abrdn Life Sciences Investors? Sign up to receive the latest short interest report for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHQL Short Interest Over TimeHQL Days to Cover Over TimeHQL Percentage of Float Shorted Over Time Remove Ads Abrdn Life Sciences Investors Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202560,400 shares $781,878.00 -37.4%0.2%0.4 $12.95 2/28/202596,500 shares $1.30 million +94.6%0.4%0.7 $13.45 2/15/202549,600 shares $694,896.00 +100.8%0.2%0.4 $14.01 1/31/202524,700 shares $351,481.00 -46.0%N/A0.2 $14.23 1/15/202545,700 shares $616,036.00 -41.3%N/A0.4 $13.48 12/31/202477,800 shares $1.02 million +212.5%N/A0.8 $13.12 12/15/202424,900 shares $344,616.00 -26.3%N/A0.3 $13.84 11/30/202433,800 shares $481,988.00 -54.4%N/A0.4 $14.26 11/15/202474,100 shares $1.02 million +17.3%N/A1 $13.72 10/31/202463,200 shares $920,192.00 +1.4%N/A1 $14.56 Get the Latest News and Ratings for HQL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. 10/15/202462,300 shares $931,385.00 -58.9%N/A0.9 $14.95 9/30/2024151,500 shares $2.28 million -1.7%N/A1.6 $15.07 9/15/2024154,100 shares $2.35 million -10.8%N/A1.6 $15.28 8/31/2024172,800 shares $2.61 million -22.0%N/A1.9 $15.13 8/15/2024221,500 shares $3.42 million -16.1%N/A2.4 $15.44 7/31/2024264,100 shares $4.06 million +4,978.9%N/A2.7 $15.37 7/15/20245,200 shares $79,456.00 -67.7%N/A0.1 $15.28 6/30/202416,100 shares $228,137.00 +67.7%N/A0.2 $14.17 6/15/20249,600 shares $132,671.04 -72.4%N/A0.1 $13.82 5/31/202434,800 shares $463,536.00 -52.7%N/A0.4 $13.32 5/15/202473,600 shares $1.05 million +26.0%N/A0.9 $14.27 4/30/202458,400 shares $765,624.00 +205.8%N/A0.6 $13.11 4/15/202419,100 shares $247,918.00 -10.3%N/A0.2 $12.98 3/31/202421,300 shares $290,319.00 -27.6%N/A0.2 $13.63 3/15/202429,400 shares $396,900.00 -47.5%N/A0.2 $13.50 2/29/202456,000 shares $767,200.00 -58.0%N/A0.4 $13.70 2/15/2024133,400 shares $1.87 million +895.5%N/A1 $14.05 1/31/202413,400 shares $183,848.00 -86.2%N/A0.1 $13.72 1/15/202496,900 shares $1.37 million +37.1%N/A0.8 $14.16 12/31/202370,700 shares $951,622.00 +30.2%N/A0.5 $13.46 12/15/202354,300 shares $714,045.00 +18.0%N/A0.4 $13.15 11/30/202346,000 shares $549,240.00 -51.0%N/A0.4 $11.94 11/15/202393,800 shares $1.13 million +186.0%N/A0.8 $12.04 10/31/202332,800 shares $380,152.00 -42.9%N/A0.3 $11.59 10/15/202357,400 shares $704,872.00 +71.9%N/A0.5 $12.28 9/30/202333,400 shares $416,498.00 -7.2%N/A0.3 $12.47 9/15/202336,000 shares $461,880.00 +40.1%N/A0.4 $12.83 8/31/202325,700 shares $334,357.00 +71.3%N/A0.3 $13.01 8/15/202315,000 shares $201,300.00 -63.0%N/A0.2 $13.42 7/31/202340,500 shares $544,725.00 +282.1%N/A0.4 $13.45A brutally honest economic warning for 2025 (see proof) (Ad)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....Full details here. 7/15/202310,600 shares $142,146.00 -85.7%N/A0.1 $13.41 6/30/202374,000 shares $1.00 million +695.7%N/A1 $13.55 6/15/20239,300 shares $128,712.00 No ChangeN/A0.1 $13.84 5/31/20239,300 shares $123,597.00 -76.6%N/A0.1 $13.29 5/15/202339,800 shares $559,588.00 -27.2%N/A0.5 $14.06 4/30/202354,700 shares $761,971.00 -2.0%N/A0.7 $13.93 4/15/202355,800 shares $782,874.00 -1.8%N/A0.7 $14.03 3/31/202356,800 shares $791,224.00 -45.8%N/A0.7 $13.93 3/15/2023104,700 shares $1.44 million +408.3%N/A1 $13.72 2/28/202320,600 shares $287,576.00 +186.1%N/A0.2 $13.96 2/15/20237,200 shares $105,336.00 -22.6%N/A0.1 $14.63 1/31/20239,300 shares $138,942.00 -17.7%N/A0.1 $14.94 1/15/202311,300 shares $166,788.00 -50.9%N/A0.1 $14.76 12/30/202223,000 shares $326,830.00 +62.0%N/A0.2 $14.21 12/15/202214,200 shares $209,024.00 -10.7%N/A0.1 $14.72 11/30/202215,900 shares $239,772.00 +28.2%N/A0.2 $15.08 11/15/202212,400 shares $186,620.00 +7.8%N/A0.1 $15.05 10/31/202211,500 shares $168,475.00 -62.9%N/A0.1 $14.65 10/15/202231,000 shares $427,490.00 No ChangeN/A0.4 $13.79 9/30/202224,000 shares $327,840.00 -33.9%N/A0.3 $13.66 9/15/202236,300 shares $537,240.00 +80.6%N/A0.5 $14.80 8/31/202220,100 shares $290,244.00 +55.8%N/A0.3 $14.44 8/15/202212,900 shares $210,399.00 +79.2%N/A0.2 $16.31 7/31/20227,200 shares $107,424.00 -77.1%N/A0.1 $14.92 7/15/202231,400 shares $475,082.00 +91.5%N/A0.4 $15.13 6/30/202216,400 shares $233,372.00 +11.6%N/A0.2 $14.23 6/15/202214,700 shares $198,156.00 +110.0%N/A0.2 $13.48 5/31/20227,000 shares $101,990.00 -84.6%N/A0.1 $14.57 5/15/202245,400 shares $653,760.00 -30.5%N/A0.6 $14.40 4/30/202265,300 shares $1.01 million +262.8%N/A0.9 $15.49 4/15/202218,000 shares $303,660.00 -1.1%N/A0.2 $16.87 3/31/202218,200 shares $301,028.00 -55.6%N/A0.2 $16.54 3/15/202241,000 shares $637,550.00 -67.6%N/A0.4 $15.55 2/28/2022126,600 shares $2.09 million -36.0%N/A1.4 $16.47 2/15/2022197,700 shares $3.48 million -18.6%N/A2.1 $17.61 1/31/2022243,000 shares $4.41 million +130.6%N/A2.8 $18.15 1/15/2022105,400 shares $1.96 million +626.9%N/A1.2 $18.56 12/31/202114,500 shares $278,835.00 -85.8%N/A0.2 $19.23 12/15/2021102,200 shares $1.95 million -5.0%N/A1.5 $19.10 11/30/2021107,600 shares $2.13 million -29.9%N/A1.7 $19.84 11/15/2021153,400 shares $3.15 million -0.5%N/A2.5 $20.54 10/29/2021154,100 shares $3.28 million +553.0%N/A2.2 $21.27 10/15/202123,600 shares $487,576.00 +34.9%N/A0.3 $20.66 9/30/202117,500 shares $364,000.00 -61.8%N/A0.3 $20.80 9/15/202145,800 shares $996,608.00 +70.3%N/A0.7 $21.76 8/31/202126,900 shares $587,765.00 -40.5%N/A0.4 $21.85 8/13/202145,200 shares $980,840.00 +396.7%N/A0.6 $21.70 7/30/20219,100 shares $189,280.00 +37.9%N/A0.1 $20.80 7/15/20216,600 shares $135,894.00 -85.5%N/A0.1 $20.59 6/30/202145,500 shares $975,520.00 +792.2%N/A0.6 $21.44A brutally honest economic warning for 2025 (see proof) (Ad)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....Full details here. 6/15/20215,100 shares $106,335.00 -88.5%N/A0.1 $20.85 5/28/202144,400 shares $884,892.00 -5.7%N/A0.5 $19.93 5/14/202147,100 shares $901,494.00 -12.9%N/A0.5 $19.14 4/30/202154,100 shares $1.10 million +12.0%N/A0.6 $20.34 4/15/202148,300 shares $951,993.00 -60.5%N/A0.6 $19.71 3/31/2021122,300 shares $2.39 million +38.7%N/A1.4 $19.51 3/15/202188,200 shares $1.78 million -23.8%N/A1.1 $20.23 2/26/2021115,700 shares $2.43 million +105.9%N/A1.4 $21.00 2/12/202156,200 shares $1.23 million +561.2%N/A0.7 $21.85 1/29/20218,500 shares $171,785.00 -76.7%N/A0.1 $20.21 1/15/202136,400 shares $744,016.00 -25.3%N/A0.5 $20.44 12/31/202048,700 shares $963,773.00 +549.3%N/A0.6 $19.79 12/15/20207,500 shares $145,200.00 -86.4%N/A0.1 $19.36 11/30/202055,000 shares $1.03 million +63.7%N/A0.7 $18.73 11/15/202033,600 shares $612,864.00 -19.2%N/A0.4 $18.24 10/30/202041,600 shares $715,104.00 +222.5%N/A0.5 $17.19 10/15/202012,900 shares $236,844.00 -18.4%N/A0 $18.36 9/30/202015,800 shares $277,764.00 -81.4%N/A0.2 $17.58 9/15/202011,000 shares $196,350.00 -87.1%N/A0.1 $17.85 8/31/202085,000 shares $1.52 million +135.5%N/A1 $17.83 8/14/202036,100 shares $646,190.00 -37.4%N/A0.4 $17.90 7/31/202057,700 shares $1.03 million +262.9%N/A0.6 $17.91 7/15/202015,900 shares $293,832.00 +40.7%N/A0.2 $18.48 6/30/202011,300 shares $199,332.00 -65.7%N/A0.1 $17.64 6/15/202032,900 shares $567,854.00 -9.6%N/A0.3 $17.26 5/29/202036,400 shares $642,460.00 +318.4%N/A0.3 $17.65 5/15/20208,700 shares $150,945.00 -71.8%N/A0.1 $17.35 4/30/202030,800 shares $528,836.00 +13.7%N/A0.2 $17.17 4/15/202027,100 shares $437,394.00 +88.2%N/A0.2 $16.14 3/31/202014,400 shares $250,128.00 +251.2%N/A0.1 $17.37 HQL Short Interest - Frequently Asked Questions What is Abrdn Life Sciences Investors' current short interest? Short interest is the volume of Abrdn Life Sciences Investors shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 60,400 shares of HQL short. 0.25% of Abrdn Life Sciences Investors' shares are currently sold short. Learn More on Abrdn Life Sciences Investors' current short interest. What is a good short interest percentage for Abrdn Life Sciences Investors? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of Abrdn Life Sciences Investors' floating shares are currently sold short. Is Abrdn Life Sciences Investors' short interest increasing or decreasing? Abrdn Life Sciences Investors saw a drop in short interest in March. As of March 15th, there was short interest totaling 60,400 shares, a drop of 37.4% from the previous total of 96,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Abrdn Life Sciences Investors' short interest compare to its competitors? 0.25% of Abrdn Life Sciences Investors' shares are currently sold short. Here is how the short interest of companies in the industry of "financial services" compare to Abrdn Life Sciences Investors: Goldman Sachs BDC, Inc. (1.22%), MidCap Financial Investment Co. (0.87%), New Mountain Finance Co. (1.49%), Bain Capital Specialty Finance, Inc. (0.42%), BlackRock MuniHoldings California Quality Fund, Inc. (0.09%), Barings BDC, Inc. (0.71%), AllianceBernstein Global High Income Fund (0.03%), Abrdn Healthcare Investors (0.13%), Carlyle Secured Lending, Inc. (0.77%), PIMCO High Income Fund (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Abrdn Life Sciences Investors stock? Short selling HQL is an investing strategy that aims to generate trading profit from Abrdn Life Sciences Investors as its price is falling. HQL shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abrdn Life Sciences Investors? A short squeeze for Abrdn Life Sciences Investors occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HQL, which in turn drives the price of the stock up even further. How often is Abrdn Life Sciences Investors' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HQL, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Goldman Sachs BDC Short Interest Data MidCap Financial Investment Short Interest Data New Mountain Finance Short Interest Data Bain Capital Specialty Finance Short Interest Data BlackRock MuniHoldings California Quality Fund Short Interest Data Barings BDC Short Interest Data AllianceBernstein Global High Income Fund Short Interest Data Abrdn Healthcare Investors Short Interest Data Carlyle Secured Lending Short Interest Data PIMCO High Income Fund Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HQL) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HQL Stock Free HQL Stock Alerts